DrugPatentWatch Database Preview
Drugs in Development Information for Icaritin
» See Plans and Pricing
What is the drug development status for Icaritin?
Icaritin is an investigational drug.
There have been 4 clinical trials for Icaritin.
The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2013.
The most common disease conditions in clinical trials are Osteoporosis, Cardiovascular Diseases, and Carcinoma, Hepatocellular. The leading clinical trial sponsors are Chinese Academy of Medical Sciences, Beijing Shenogen Biomedical Co., Ltd, and National University Hospital, Singapore.
There are three US patents protecting this investigational drug and thirteen international patents.
Summary for Icaritin
| US Patents | 3 |
| International Patents | 13 |
| US Patent Applications | 4 |
| WIPO Patent Applications | 42 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2013-10-01) |
| Vendors | 52 |
Recent Clinical Trials for Icaritin
| Title | Sponsor | Phase |
|---|---|---|
| Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease | National University Hospital, Singapore | Phase 1 |
| The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma | 307 Hospital of PLA | Phase 2 |
| The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma | Chinese Academy of Medical Sciences | Phase 2 |
Clinical Trial Summary for Icaritin
Top disease conditions for Icaritin
Top clinical trial sponsors for Icaritin
US Patents for Icaritin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Icaritin | Start Trial | Compositions comprising icariside I and anhydroicaritin and methods for making the same | Hauser, Inc. (Boulder, CO) | Start Trial |
| Icaritin | Start Trial | Compounds and methods for treating estrogen receptor-related diseases | Shenogen Pharma Group Ltd. (Beijing, CN) | Start Trial |
| Icaritin | Start Trial | Cosmetic composition containing hydrolysates of icariin | Amorepacific Corporation (Seoul, KR) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Icaritin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Icaritin | Australia | AU8060401 | 2020-08-15 | Start Trial |
| Icaritin | World Intellectual Property Organization (WIPO) | WO0213842 | 2020-08-15 | Start Trial |
| Icaritin | China | CN101528038 | 2026-10-25 | Start Trial |
| Icaritin | European Patent Office | EP2096916 | 2026-10-25 | Start Trial |
| Icaritin | Japan | JP2010508284 | 2026-10-25 | Start Trial |
| Icaritin | Japan | JP5265556 | 2026-10-25 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
